The emerging treatment of this peptide represents a major breakthrough in the handling of the condition. Different to existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide928301.answerblogs.com/42397766/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment